Skip to main content
SpringerLink
Log in

Pharmacotherapy update in the management of paediatric cancer

  • Conference Commentary
  • Published:
Pharmacy World & Science Aims and scope Submit manuscript

Abstract

Great advances in the treatment of childhood cancer have been made over the last 30 years because of developments in supportive care, the increasing use of advanced technology to detect and diagnose disease, developments in the understanding and relevance of cell biology and by the successful recruitment of children into nationally co-coordinated clinical trials. For some childhood malignancies where the survival rate is high, trials are ongoing to see if treatment can be stratified and directed according to patient risk, with those that fall into a favourable risk category potentially being cured with less treatment and therefore less short term and long term toxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. CRUK childhood cancer incidence. 2010. http://info.cancerresearchuk.org/cancerstats/childhoodcancer/incidence/index.htm. Accessed 27 June 2010.

  2. CRUK childhood cancer treatment. 2010.http://info.cancerresearchuk.org/cancerstats/childhoodcancer/treatmentfollowup/index.htm. Accessed 27 June 2010.

  3. CRUK childhood cancer trends. 2010. http://info.cancerresearchuk.org/cancerstats/childhoodcancer/trends/index.htm. Accessed 27 June 2010.

  4. The rules governing medicinal products in the European Union Volume 10 clinical trials. 2010. http://ec.europa.eu/health/documents/eudralex/vol-10/index_en.htm. Accessed 27 June 2010.

  5. Buckham J. How can we ensure child friendly oral chemotherapy agents are available? Pharm J. 2010;284:399–402.

    Google Scholar 

  6. Conroy S, Newman C, Gudka S. Unlicensed and off-label drug use in acute lymphoblastic leukaemia and other malignancies in Children. Ann Oncol. 2003;14:42–7.

    Article  CAS  PubMed  Google Scholar 

  7. Breitkreutz J, Buckham J, Fischer R, Postges R, Boos J. Comparative in vitro studies on different 6-mercaptopurine formulations for use in children. Paediatr Perinat Drug Ther. 2007;8(1):31–39

    Article  Google Scholar 

  8. NICE 2005. Improving outcomes for children and young people with cancer. http://www.nice.org.uk/nicemedia/live/10899/28876/28876.pdf. Accessed 27 June 2010.

  9. DH National Cancer Action Team Manual for Cancer Services 2008: children’s cancer measures. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_108670.pdf. Accessed 27 June 2010.

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Principal Pharmacist Paediatric Oncology, Royal Marsden NHS Foundation Trust, Sutton Surrey, UK

    Julie Mycroft

Authors
  1. Julie Mycroft
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Julie Mycroft.

Additional information

This paper describes a lecture to be given at the 39th European Symposium of Clinical Pharmacy, Lyon, 2010.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mycroft, J. Pharmacotherapy update in the management of paediatric cancer. Pharm World Sci 32, 549–551 (2010). https://doi.org/10.1007/s11096-010-9425-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-010-9425-6

Keywords

Search

Navigation